Carfilzomib Weekly 20/56mg/m², Lenalidomide and Dexamethasone for Early Relapsed Refractory Multiple Myeloma

Bibliographic Details
Title:	Carfilzomib Weekly 20/56mg/m², Lenalidomide and Dexamethasone for Early Relapsed Refractory Multiple Myeloma
Authors:	Richez, Valentine ^, Gruchet, Cécile ^, Guidez, Stephanie ^, Fouquet, Guillemette ^, Azais, Isabelle ^, Durand, Geraldine ^, Javaugue, Vincent ^, Brigaud, Antoine ^, Plasse, Florent ^, Diolez, Jeremie ^, Machet, Antoine ^, Moya, Niels ^, Gardeney, Helene ^, Franques, Paul ^, Bobin, Arthur ^, Levy, Anthony ^, Sabirou, Florence ^, Bonnin, Anthony ^, Dieval, Celine ^, Primault, Sylvain ^, Barrier, Jocelyn ^, Fleck, Emmanuel ^, Bouyier, Sabrina ^, Daras, Claire ^, Princet, Isabelle ^, Bauwens, Delphine ^, Legros, Laurence ^, Fuzibet, Jean-Gabriel ^, Gil, Angela ^, Bridoux, Franck ^, Avet-Loiseau, Hervé ^*, Leleu, Xavier
Source:	In Blood 29 November 2018 132 Supplement 1:3276-3276
Database:	ScienceDirect